Nuclear medicine and physics

Composition:

Chair: Katia Olianti (Itlay) catia.olianti@unifi.it
Vice chair: Julia Balaguer (Spain) balaguer_jul@gva.es

Members:

• Bieke Lambert (Belgium)

• Tereza Kracmerova (Czech Republic)

• Katerina Taborska (Czech Republic)

• Vedrana Gladic (Czech Republic)

• Lize Borgwardt (Denmark)

• Anni Morsing (Denmark)

• Anne Sophie Defachelles (France)

• Holger Amthauer (Germany)

• Julian Rogash (Germany)

• Vassiliki Lyra (Greece)

• Zvi Bar-Sever (Israel)

• Giulia Anna Follacchio (Italy)

• Bartolomeo Cassano (Italy)

• Gianluca Bottoni (Italy)

• Maria Rita Castellani (Italy)

• Carlo Chiesa (Italy)

• Anna Lisa Martini (Italy)

• Arnoldo Piccardo (Italy)

• Milena Pizzoferro (Italy)

• Paola Saletti (Italy)

• Maria Felicia Villani (Italy)

• Maria Carmen Garganese (Italy)

• Lars Mikalsen (Norway)

• Anna Sliwinska (Poland)

• Karolina Switaj (Poland)

• Teresa Ferreira (Portugal)

• Pablo Minguez Gabina (Spain)

• Stefan Prado (Spain)

• Isabel Roca (Spain)

• Raquel Sanchez (Spain)

• Irene Torres (Spain)

• Bart de Keizer (The Netherlands)

• Matthew Aldridge (UK)

• Glenn Flux (UK)

• Hugh Wallace (UK)

• Simon Wan (UK)

---

Aims

Specific deliverable objective(s) for next 1 year:

• SIOPEN Scoring definition. Comparison of different evaluation among Nuc-Med members as already assessed.  Producing GL to score with high inter-observer reproducibility.

• Scoring a MIBG data set in a selected cohort of patients with RTqPCR mRNA vs mIBG study in HR-NB1.

• Anti-GD2-PET tracer in induction and maintenance therapy.

• Review of literature on T CD8-positive cells with 89Zr-PET tracer during immunotherapy and immunoresponse.

Objectives for the next 5 years:

• Research and publications about the above-listed researches.

• Chair and the co-chair election allowing young members to take these positions in October 2024 end of them.

Key achievements

• Position paper on imaging of HR-NB and NUCMed/Physics work group with Radiology Committee

• Co-working with QoL – LTO and BIOPORTAL for  eCRF collaborative work

• mRT-qPCR Committee for a comparison with MIBG Scoring values.

• Consultings (n°2  in HR-NB 123I-mIBG)

• Metabolic radiotherapy and dosimetry meaning in children with pheochromocytoma/paraganglioma/ganglioneuroma/neuroblastoma

• 3D radiological/nuclear medicine merged imaging in the presurgical evaluation and post-surgical assessment of residual tumor.

Selected outputs

1. EANM’20 Virtual - Presentation ID EP-224 : Simplify scoring System vs SIOPEN in prognosis risk assessment in Neuroblastoma. C. Olianti1, M. Allocca2, A. Martini2, A. Tondo3, H. Gauthier4. B91 Paediatric Study.

2. EANM’20 Virtual - OP 346 : SIOPEN SCORING vs 3 Simplified Scoring Systems in Pediatric Patients with HR-NB-1 and L2-NB. C. Olianti, A. Martini, R. Di Dato, M. Allocca, A. Tondo, H. Gauthier. B91 Paediatric Study.

3. EANM’20 Virtual - EP-362 - Tandem High-Dose 131I-MIBG Therapy For Paediatric Patients With Relapsed-Refractory High Risk Neuroblastoma: A Dosimetry Based Treatment . C. Altini, M. Villani, B. Cassano, M. Pizzoferro, A. Serra, A. Castellano, V. Cannatà, M. Garganese.

4. EANM’20 Virtual - A correlation study between clinical outcome and absorbed dose to organs at risk and lesions for patients with High-Risk Neuroblastoma administered with highactivity therapy of 131I-mIBG. B. Cassano, M. Pizzoferro, S. Valeri, S. Donatiello, C. Polito, D. Ciucci, F. Martire A. Castellano, C. Altini, M. C. Garganese V. Cannatà.

5. EANM’20 Virtual - OP-428 Calibration, radioprotection and dosimetry in Lu-177 treatment of Neuro Endocrine tumours. P. Saletti, S. Raspanti, A. D’Agata, F. Rossi, M. Papi, G. Belli.

6. EANM’20 Virtual - EPS-040 Gamma Camera Calibration to Perform SPECT/CT-based Dosimetry in 177Lu-DOTATATE Treatments. T. Monserrat Fuertes, N. Montenegro Iglesias, D. Álvarez S104Llorente, M. Peinado Montes, D. San José Olmedo, P. Mínguez.

7. EANM’20 Virtual - OP-902. Printing 3D Heterogeneous Activity Distributions for Quality Control of SPECT and PET. J. Gear, G. Flux.

8. EANM’20 Virtual - OP-180. Initial experience with 177lutetium peptide receptor radionuclide therapy for pediatric patients with somatostatin-receptor-positive tumors
   M. Pizzoferro, B. Cassano, C. Altini, A. Serra, M. Cefalo, A. Cacchione, M. Villani, A. Castellano, V. Cannatà, M. Garganese.

---

Interested in joining the Specialty committee?

Please first register to become a SIOPEN member and then contact the specialty committee chair and/or co-chair in order to join the committee.